article thumbnail

AI-driven drug company secures $372m Series D funding

Drug Discovery World

Formation Bio, a tech-driven and AI-native pharma company, has raised $372 million in a Series D financing. “We are thrilled to partner with the Formation Bio team on their journey to build an AI-enabled pharma company,” said Scott Kupor, Managing Partner at a16z.

article thumbnail

Post-COVID-19 cognitive impairment: a new target for drug development?

Drug Discovery World

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. These may provide an opportunity for treatment for post-Covid-19 cognitive impairment.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Key Challenges of Specialty Pharma Drug Development Project Management

thought leadership

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases , cancer, and other complex conditions. These drugs often require significant investment in research and development, and their development requires careful project management.

article thumbnail

Why Do Pharma Companies Outsource to CROs?

Vial

Focus on core competencies : By outsourcing trial management to CROs, pharmaceutical companies and research institutions can concentrate on drug development and scientific innovation, rather than administrative tasks. Their ability to adapt to evolving regulations and industry standards reduces the likelihood of costly setbacks.

article thumbnail

77% of researchers not using alternatives to animal testing

Drug Discovery World

More than 350 survey respondents participated in the survey by The Pistoia Alliance, including representatives from pharma companies, regulators, and CROs. Companies are excited by the possibility of producing more accurate models than traditional animal testing that could speed up drug development and support their ESG goals.

article thumbnail

SLAS2024 speaker update: How tech is reducing failure rates in clinical trials

Drug Discovery World

Dr Bentwich will present on ‘ How artificial intelligence and patient-on-a-chip are improving drug development ’ on Tuesday 6 February at 3pm. His presentation will explore the impact of Quris-AI’s Bio-AI platform in the field of drug development.

article thumbnail

Women in STEM with Kristina Torfgard

Drug Target Review

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.